SI-1 (0.2 mg/kg) could not exert antitumor activity but could significantly inhibit SREBP-1 activation (Figure 4F), the Warburg effect in HCC cells in tumor tissues (Figure 4F), or EMT (Figure 4F). The gene discussed is SREBF1; the disease is hepatocellular carcinoma.